Yutaka Fujiwara

24PUBLICATIONS
65CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Mar 31, 2025
Randomized Phase III Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-Doublet Chemotherapy for Non-Small Cell Lung Cancer Harboring EGFR Mutation.

Shintaro Kanda, Seiji Niho, Takayasu Kurata

|Oct 26, 2024
ARAF Amplification in Small-Cell Lung Cancer-Transformed Tumors Following Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors.

Ryo Kimura, Yuta Adachi, Kentaro Hirade

|Jan 27, 2023
Pharmacokinetic and dose-finding study of osimertinib in patients with impaired renal function and low body weight.

Yutaka Fujiwara, Reiko Makihara, Tetsunari Hase

|Sep 09, 2022
First-in-human study of ONO-4578, an antagonist of prostaglandin E2 receptor 4, alone and with nivolumab in solid tumors.

Satoru Iwasa, Takafumi Koyama, Makoto Nishino

|Jun 07, 2022
Phase I Study of Tremelimumab Monotherapy or in Combination With Durvalumab in Japanese Patients With Advanced Solid Tumors or Malignant Mesothelioma.

Yutaka Fujiwara, Yasuo Takahashi, Morihito Okada

|Mar 14, 2022
Successful IMRT and concurrent chemotherapy for a patient with intrathoracic extensive-stage small cell lung cancer.

Yoshitsugu Horio, Hiroyuki Tachibana, Junichi Shimizu

Pageof 4

Frequent Collaborators

9 joint publications

Noboru Yamamoto

7 joint publications

Yuichiro Ohe

6 joint publications

Takafumi Koyama

4 joint publications

Kan Yonemori